Key result
Transcatheter aortic valve implantation for severe symptomatic aortic stenosis was associated with a 5-year mortality of 59.1%, with predictors including renal failure and residual aortic regurgitation.
Population
1,444 elderly patients with severe symptomatic aortic stenosis from the German Transcatheter Aortic Valve…
Design
Cohort
Follow-up
5 years
Authors
Loading...
High 5-year TAVI mortality in this cohort warrants careful patient selection; leaves open whether targeting modifiable predictors improves outcomes.
Cohort (n=1,444)
Yes
In an early TAVI registry cohort, 5-year mortality was high (59.1%), driven by several baseline and procedural factors including modifiable ones like residual aortic regurgitation and access route.
Zahn et al. (2017) conducted a cohort in severe symptomatic aortic stenosis (n=1,444). Transcatheter aortic valve implantation (TAVI) was evaluated on 5-year mortality. Transcatheter aortic valve implantation for severe symptomatic aortic stenosis was associated with a 5-year mortality of 59.1%, with predictors including renal failure and residual aortic regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: